<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cilostazol, a selective inhibitor of phosphodiesterase 3, exerts neuroprotective effects on <z:hpo ids='HP_0011009'>acute</z:hpo> brain injury after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is unknown whether cilostazol affects the <z:hpo ids='HP_0011011'>subacute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> ischemic injury </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we evaluated the dose- and time-dependent effects of cilostazol on <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic brain injury and the long-lasting effect on the late (<z:hpo ids='HP_0011011'>subacute</z:hpo>/<z:hpo ids='HP_0011010'>chronic</z:hpo>) injury in mice with focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We found that pre-treatment of cilostazol (injected i.p. at 30 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) significantly ameliorated the <z:hpo ids='HP_0011009'>acute</z:hpo> injury 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and the effective doses were 3-10 mg/kg </plain></SENT>
<SENT sid="4" pm="."><plain>The post-treatment of cilostazol (10 mg/kg) was effective on the <z:hpo ids='HP_0011009'>acute</z:hpo> injury when it was injected 1 and 2 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, for the late injury, post-treatment of cilostazol (10 mg/kg, i.p., for 7 consecutive days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) attenuated neurological dysfunctions, brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="6" pm="."><plain>It also inhibited astrocyte proliferation/glial scar formation and accelerated the <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in the ischemic boundary zone 7 and 28 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, we conclude that cilostazol protects against not only the <z:hpo ids='HP_0011009'>acute</z:hpo> injury, but also the late injury in mice with focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>; especially it can modify brain remodeling, <z:mp ids='MP_0003354'>astrogliosis</z:mp> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
</text></document>